FundedIQ
Biotechnology

GreenMark Biomedical: Funding, Investors & Team (Nov 2026)

GreenMark is a healthcare company providing health-based benefits using nanoparticles. The company develops technologies that involve biopolymer nanoparticles produced from natural starch as a raw material.

greenmark.bio LinkedIn East Lansing, United States 11-50 employees
Biotechnology Clinical Trials Health Care Hospital Medical Device
Total raised
$480k
Rounds
2
Latest
Undisclosed round
Jul 2025

GreenMark Biomedical has raised $480k across 2 funding rounds on record, the most recent an undisclosed round of $160k announced in Jul 2025.

That round is below the $8.9M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

GreenMark Biomedical Company Profile and Key Stats

Total funding raised
$480k
across 2 rounds on record
Funding rounds on record
2
Latest funding round
Undisclosed round
$160k in Jul 2025
Employees
11-50
reported band
Headquarters
East Lansing, United States

Latest funding round on record: Jul 2025.

GreenMark Biomedical Funding Rounds

Date
Round
Amount
Undisclosed round
$160k
Undisclosed round
$320k

GreenMark Biomedical raised $320k in an undisclosed round announced in Apr 2025.

3 months later, an undisclosed round of $160k was announced in Jul 2025.

GreenMark Biomedical Founders and Leadership Team

Name
Role
Contact
Steven Bloembergen
Founder
Locked

Contact details for the GreenMark Biomedical team: 1 of 1 has an email address on file.

Start 14-day free trial →

GreenMark Biomedical Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,188
$8.9M
30,615
$7.8M

GreenMark Biomedical's latest round of $160k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like GreenMark Biomedical in Biotechnology and East Lansing

Companies Similar to GreenMark Biomedical

Araceli Biosciences specializes in creating scientific instruments for discovering tissue- and cell-based…

Seed $4.5M

Switchpoint Bio is a biotechnology company that offers immune relevant drug treatments.

Pre-Seed $5.3M

Nanopath Inc. is a company that specializes in molecular diagnostics and allows for fast, high-quality…

Series B $25.0M

Frontier Bio is creating lab-grown human tissues as an ethical replacement for animal studies and is setting…

Undisclosed round $380k

Delix Therapeutics is a neuroscience company focused on harnessing the power of psychoplastogens—novel…

Series C $100M

Rgenta Therapeutics develops a pipeline of oral, small-molecule RNA-targeting medicines with an initial focus…

Series B $41.9M

Zafrens, a pharmaceutical research organization, focuses on designing life sciences solutions for…

Series A $6.0M

Quanta is a biotechnology company uncovering novel cancer therapeutic candidates to target driver oncogenes.…

Series D —

Arctic Therapeutics specializes in finding the genetic origins of common diseases and creating successful…

Undisclosed round $21.5M

100XBIO is creating a cutting-edge platform for analyzing multiple T-cells automatically, aiming to…

Pre-Seed $110k

MEND is a company focused on life sciences, determined to assist individuals in achieving better health…

Undisclosed round $1.5M

Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…

Series B $50.0M

GreenMark Biomedical Funding FAQs

What does GreenMark Biomedical do?

GreenMark is a healthcare company providing health-based benefits using nanoparticles. The company develops technologies that involve biopolymer nanoparticles produced from natural starch as a raw material.

How much funding has GreenMark Biomedical raised?

GreenMark Biomedical has raised $480k across 2 rounds on record. The most recent is an undisclosed round of $160k announced in Jul 2025.

When did GreenMark Biomedical last raise funding?

GreenMark Biomedical's most recent funding round on record is an undisclosed round of $160k, announced in Jul 2025.

Who founded GreenMark Biomedical?

FundedIQ lists Steven Bloembergen (Founder) at GreenMark Biomedical.

Where is GreenMark Biomedical headquartered?

GreenMark Biomedical is based in East Lansing, Michigan, United States.

How many employees does GreenMark Biomedical have?

GreenMark Biomedical is in the 11-50 employee band.

How does GreenMark Biomedical's funding compare to other Biotechnology startups?

GreenMark Biomedical's latest round of $160k is below the $8.9M median round size for Biotechnology companies on FundedIQ across 4,188 tracked companies over the last two years.

About FundedIQ's GreenMark Biomedical Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for GreenMark Biomedical is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.